Karin Palmblad, Hanna Schierbeck, Erik Sundberg, Anna-Carin Horne, Helena Erlandsson Harris, Jan-Inge Henter, & Ulf Andersson. (2021). Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome. BMC.
Chicago Style (17th ed.) CitationKarin Palmblad, Hanna Schierbeck, Erik Sundberg, Anna-Carin Horne, Helena Erlandsson Harris, Jan-Inge Henter, and Ulf Andersson. Therapeutic Administration of Etoposide Coincides with Reduced Systemic HMGB1 Levels in Macrophage Activation Syndrome. BMC, 2021.
MLA (9th ed.) CitationKarin Palmblad, et al. Therapeutic Administration of Etoposide Coincides with Reduced Systemic HMGB1 Levels in Macrophage Activation Syndrome. BMC, 2021.
Warning: These citations may not always be 100% accurate.